Is Cancer Confined to the Prostate Gland?
These tables may help you and your doctor to predict the chance of organ confined prostate cancer.
Find the table headed with your PSA level. Next, read down the left (orange) column to your Gleason score. Then read across to the column headed by your clinical stage (e.g T2a).
Where the row for your Gleason meets the column for your clinical stage is a number. This number, e.g. 66, is a percentage - 66%. Your number gives you a rough idea of how many chances out of a hundred a patient with your PSA level, Gleason score and Clinical Stage has of organ confined disease. The higher this number, the better. Remember you're NOT an "average" number!
PSA 0.0 - 4.0 ng/mL
|
Clinical Stage |
T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
Gleason Score |
Percent probability that prostate cancer is organ-confined
|
2-4 |
90 |
80 |
89 |
81 |
72 |
77 |
|
5 |
82 |
66 |
81 |
68 |
57 |
62 |
40 |
6 |
78 |
61 |
78 |
64 |
52 |
57 |
35 |
7 |
|
43 |
63 |
47 |
34 |
38 |
19 |
8-10 |
|
31 |
52 |
36 |
24 |
27 |
|
PSA 4.1 - 10.0 ng/mL |
Clinical Stage |
T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
Gleason score |
Percent probability
|
2-4 |
84 |
70 |
83 |
71 |
61 |
66 |
43 |
5 |
72 |
53 |
71 |
55 |
43 |
49 |
27 |
6 |
67 |
47 |
67 |
51 |
38 |
43 |
23 |
7 |
49 |
29 |
49 |
33 |
22 |
25 |
11 |
8-10 |
35 |
18 |
37 |
23 |
14 |
15 |
6 |
PSA 10.1 - 20.0 ng/mL
|
Clinical Stage |
T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
Gleason score |
Percent probability
|
2-4 |
76 |
58 |
75 |
60 |
48 |
53 |
|
5 |
61 |
40 |
60 |
43 |
32 |
36 |
18 |
6 |
|
33 |
55 |
38 |
26 |
31 |
14 |
7 |
33 |
17 |
35 |
22 |
13 |
15 |
6 |
8-10 |
|
9 |
23 |
14 |
7 |
8 |
3 |
PSA above 20.0 ng/mL
|
Clinical Stage |
T1a |
T1b |
T1c |
T2a |
T2b |
T2c |
T3a |
Gleason score |
Percent probability
|
2- 4 |
|
38 |
58 |
41 |
29 |
|
|
5 |
|
23 |
40 |
26 |
17 |
19 |
8 |
6 |
|
17 |
35 |
22 |
13 |
15 |
6 |
7 |
|
|
18 |
10 |
5 |
6 |
2 |
8-10 |
|
3 |
10 |
5 |
3 |
3 |
1 |
Chart source: Management of Prostate Cancer
ed. Eric Klein, MD, Humana Press, Inc, 2000.
Chart adapted from Sohayda C, Kupelian PA, Klein E.
Extent of extracapsular extension:
implications for planning conformal radiotherapy and brachytherapy.
Int J Radiation Oncol Biol Phys 1998; 42:132
|
This page compiled by J. Strax April 20, 2006; last modified December 26 2008.
© 1997-2009 PSA Rising
|
Online calculators:
For detailed results showing
Probability of Organ Confined Disease, Extraprostatic Extension, Seminal Vesicle Invasion , and Lymph Node Invasion
consult
PSA velocity is a key measure of cancer risk.
A PSA velocity calculator is online
at Urological Sciences Research Foundation
|